Todd Davis
InvestorChief Executive Officer at Ligand Pharmaceuticals
Find your path to Todd
21 people in our graph can introduce you to Todd.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Richard Heyman to introduce you to Todd
You →Richard · together at Ligand Pharmaceuticals →Todd
Ask Jamie Chen to introduce you to Todd
You →Jamie · 11 people · together at Ligand Pharmaceuticals →Todd
Sign up to find every way you can get introduced to Todd
- Your email: the people you already email who know Todd
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Todd
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
CEO of Ligand and a board member since 2007, with over 30 years of healthcare operational and investment experience. He co-founded HealthCare Royalty Partners and previously invested in biopharma growth equity at Apax Partners.
Colleagues at Ligand Pharmaceuticals
Andrew Reardon
Chief Legal Officer at Ligand Pharmaceuticals
James Pipkin
Vice President, New Product Development at Ligand Pharmaceuticals
Karen Reeves
Senior Vice President, Investments and Head of Clinical Strategy at Ligand Pharmaceuticals
Keith Marschke
Senior Vice President, Biology and Scientific Affairs at Ligand Pharmaceuticals
Lauren Hay
Vice President, Portfolio Strategy and Investments at Ligand Pharmaceuticals
Lee Brown
Vice President, Investments and Business Development at Ligand Pharmaceuticals
Marjorie Fackovec
Head of People Operations at Ligand Pharmaceuticals
Michael Vigilante
Vice President, Investments and Business Development at Ligand Pharmaceuticals
Frequently asked questions
- Who is Todd Davis?
- CEO of Ligand and a board member since 2007, with over 30 years of healthcare operational and investment experience. He co-founded HealthCare Royalty Partners and previously invested in biopharma growth equity at Apax Partners.
- Where does Todd Davis work?
- Todd Davis is Chief Executive Officer at Ligand Pharmaceuticals.









